Biosimilar Safe Harbors Need Record Of Non-Commercial Use, Epogen Ruling Suggests

 
• By Brenda Sandburg
  
Wollongong lighthouse providing safe harbor
Federal Circuit finds Hospira's Epogen biosimilar batches were outside safe harbor from infringement suit

More from Biosimilars

More from Biosimilars & Generics